Clinical Trials Logo
  1. Home
  2. Severe Persistent Asthma
  3. NCT01197482

Inhaled Steroids and Control of Severe Asthma — INHALE  

Severe Persistent Asthma Clinical Trial

Official title:
Inhaled Steroids and Control of Severe Asthma: Comparison of the AKITA Technology Versus Conventional MDI (INHALE)

Clinical Trial Summary

Investigational device: AKITA 2 device versus conventional metered-dose inhaler (MDI) Objectives: To explore if inhalative fluticasone application by means of the AKITA technology would result in a better symptom control in patients with severe persistent asthma as compared to inhalative application of fluticasone by a conventional MDI. Study design: open label, cross-over (one AKITA, one MDI arm) Patients: 20 Patients with severe persistent asthma

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01197482
Study type Observational
Source University of Giessen
Contact
Status Terminated
Phase
Start date September 2010
Completion date December 28, 2018
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT02952066 - Expressions of TRPV1 in Airway of Asthmatics N/A
Completed NCT02559791 - Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma Phase 2/Phase 3
Recruiting NCT03617718 - Project 2 Airway Potential Hydrogen (pH) in Asthma Phase 1/Phase 2
Recruiting NCT01839591 - Bronchial Thermoplasty: Effect on Neuronal and Chemosensitive Component of the Bronchial Mucosa N/A
Withdrawn NCT00954850 - A National Program for Severe Asthma: The Canadian Severe Asthma Network N/A
Completed NCT01748175 - Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma
Withdrawn NCT01745809 - Bronchoscopy Study for Severe Asthma N/A
Completed NCT02717689 - A Pragmatic Trial of Corticosteroid Optimisation in Severe Asthma N/A
Completed NCT01750411 - Severe Asthma Research Program - Wake Forest University
Completed NCT01862289 - Prevalence of Hyperventilation Syndrome in Difficult Asthma N/A
Completed NCT02659618 - Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma
Withdrawn NCT00689806 - Evaluation of Lovastatin in Severe Persistent Asthma Phase 1/Phase 2